SILENT ACCUMULATION: UNDERSTANDING FAT DISTRIBUTION IN U.S ADULTSUSING A NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY(NHANES) SAMPLE
Stanford Digital Repository · 03.06.2025
DOI: 10.25740/pn869yt7455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stanford Digital Repository, erschienen am 03.06.2025. Verfasst von Maldonado Juliao und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Steatotic liver disease (SLD) is the newly proposed umbrella term replacing nonalcoholic fatty liver disease (NAFLD), following an international Delphi consensus. This revised nomenclature includes categories such as metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic and alcohol-related liver disease (MetALD), aiming to better reflect the central role of metabolic risk factors in hepatic steatosis. The transition away from an exclusion-based definition aligns with evolving evidence and seeks to improve clinical clarity and global research consistency.
Objective
This study used data from the National Health and Nutrition Examination Survey (NHANES) 2017–2020 cycle to estimate the prevalence of SLD among U.S. adults and assess its association with sociodemographic and metabolic risk factors.
Methods
Controlled attenuation parameter (CAP) scores from transient elastography were used to define SLD, using a threshold of ≥288 dB/m. Survey-weighted analyses were conducted to assess differences across groups, and multivariable logistic and linear regression models were used to examine associations between covariates and both SLD prevalence and CAP scores.
Results
The weighted prevalence of SLD among the entire sample cohort (n=7643) was 34.2%. The mean age was 47.1 years, 50% were males, and 34% were Non-Hispanic White. Individuals with SLD were older, more likely to be male, and of Mexican American ethnicity compared to those without SLD. Multivariable logistic regression indicated that female sex vs. male was associated with lower odds of SLD (OR= 0.52; 95% CI, 0.42–0.64), whereas Mexican American ethnicity vs. non-Hispanic whites (OR= 1.93; 95% CI, 1.47–2.55) and elevated adiposity (OR= 11.51; 95% CI, 7.27–19.21) showed increased odds. Furthermore, low HDL cholesterol (OR=2.04; 95% CI, 1.62–2.57), insulin resistance or diabetes mellitus (OR= 1.88; 95% CI, 1.50– 2.36), elevated blood pressure (OR=1.84; 95% CI, 1.49–2.26), and elevated triglycerides (OR, 1. 61; 95% CI, 1.15–2.28) were significantly associated with higher SLD odds. Linear regression showed similar associations with CAP scores.
Conclusions
These findings support the central role of metabolic dysfunction in liver steatosis. Early recognition and timely management of metabolic co-morbidities may help improve clinical outcomes among individuals with SLD.
Schlagwörter
Zitieren
APA
Juliao, M., Viviana, Popat, R. A., Wong, & Robert (2025). SILENT ACCUMULATION: UNDERSTANDING FAT DISTRIBUTION IN U.S ADULTSUSING A NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY(NHANES) SAMPLE. Stanford Digital Repository. https://doi.org/10.25740/pn869yt7455
Vancouver
Juliao M, Viviana, Popat RA, Wong, Robert. SILENT ACCUMULATION: UNDERSTANDING FAT DISTRIBUTION IN U.S ADULTSUSING A NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY(NHANES) SAMPLE. Stanford Digital Repository. 2025. doi:10.25740/pn869yt7455
BibTeX
@article{Juliao2025,
author = {Juliao, Maldonado and Viviana and Popat, Rita A. and Wong and Robert},
title = {SILENT ACCUMULATION: UNDERSTANDING FAT DISTRIBUTION IN U.S ADULTSUSING A NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY(NHANES) SAMPLE},
journal = {Stanford Digital Repository},
year = {2025},
doi = {10.25740/pn869yt7455}
}
EUVIMED